Gene expression profile analysis of an isogenic tumour metastasis model reveals a functional role for oncogene AF1Q in breast cancer metastasis.

[1]  J. Folkman.  Endothelial cells and angiogenic growth factors in cancer growth and metastasis. Introduction. , 1990, Cancer metastasis reviews.

[2]  W. Tse,et al.  A novel gene, AF1q, fused to MLL in t(1;11) (q21;q23), is specifically expressed in leukemic and immature hematopoietic cells. , 1995, Blood.

[3]  T. Noumi,et al.  Ets-related protein E1A-F can activate three different matrix metalloproteinase gene promoters. , 1995, Oncogene.

[4]  S. Narumiya,et al.  Overexpression of the rhoC gene correlates with progression of ductal adenocarcinoma of the pancreas. , 1998, British Journal of Cancer.

[5]  Alan Hall,et al.  Rho GTPases Control Polarity, Protrusion, and Adhesion during Cell Movement , 1999, The Journal of cell biology.

[6]  R Berger,et al.  MLL-AF1q fusion resulting from t(1;11) in acute leukemia , 1999, Leukemia.

[7]  N. Sampas,et al.  Molecular classification of cutaneous malignant melanoma by gene expression profiling , 2000, Nature.

[8]  H. Saeki,et al.  Expression of Ets‐1 transcription factor is correlated with penetrating tumor progression in patients with squamous cell carcinoma of the esophagus , 2000, Cancer.

[9]  S. Merajver,et al.  RhoC GTPase, a novel transforming oncogene for human mammary epithelial cells that partially recapitulates the inflammatory breast cancer phenotype. , 2000, Cancer research.

[10]  Eric S. Lander,et al.  Genomic analysis of metastasis reveals an essential role for RhoC , 2000, Nature.

[11]  M. Duffy,et al.  Metalloproteinases: role in breast carcinogenesis, invasion and metastasis , 2000, Breast Cancer Research.

[12]  P. Steeg,et al.  Molecular biology of breast cancer metastasis: Genetic regulation of human breast carcinoma metastasis , 2000, Breast Cancer Research.

[13]  T. Mcclanahan,et al.  Involvement of chemokine receptors in breast cancer metastasis , 2001, Nature.

[14]  Yudong D. He,et al.  Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.

[15]  S. Goodison,et al.  Contrasting expression of thrombospondin-1 and osteopontin correlates with absence or presence of metastatic phenotype in an isogenic model of spontaneous human breast cancer metastasis. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[16]  G. Berchem,et al.  Cathepsin-D affects multiple tumor progression steps in vivo: proliferation, angiogenesis and apoptosis , 2002, Oncogene.

[17]  S. Curran,et al.  New insights into the roles of matrix metalloproteinases in colorectal cancer development and progression , 2003, The Journal of pathology.

[18]  Shenhua Xu,et al.  Difference of gene expression profiles between esophageal carcinoma and its pericancerous epithelium by gene chip. , 2003, World journal of gastroenterology.

[19]  Philip M. Long,et al.  Breast cancer classification and prognosis based on gene expression profiles from a population-based study , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[20]  T. Nikaido,et al.  Up-Regulation of Small GTPases, RhoA and RhoC, Is Associated with Tumor Progression in Ovarian Carcinoma , 2003, Laboratory Investigation.

[21]  R. Gascoyne,et al.  Characterization of the recurrent translocation t(1;1)(p36.3;q21.1–2) in non‐Hodgkin lymphoma by multicolor banding and fluorescence in situ hybridization analysis , 2003, Genes, chromosomes & cancer.

[22]  E. Lander,et al.  A molecular signature of metastasis in primary solid tumors , 2003, Nature Genetics.

[23]  M. Hendrix,et al.  Maspin Regulates Different Signaling Pathways for Motility and Adhesion in Aggressive Breast Cancer Cells , 2003, Cancer biology & therapy.

[24]  Levon M Khachigian,et al.  Transcription factor Egr-1 supports FGF-dependent angiogenesis during neovascularization and tumor growth , 2003, Nature Medicine.

[25]  Y. Tsunematsu,et al.  Cryptic insertion and translocation or nondividing leukemic cells disclosed by FISH analysis in infant acute leukemia with discrepant molecular and cytogenetic findings , 2003, Leukemia.

[26]  Jeffrey W. Smith,et al.  Gene expression profiling of tumor xenografts: In vivo analysis of organ‐specific metastasis , 2003, International journal of cancer.

[27]  Kyoko Arai,et al.  Significant association of Rho/ROCK pathway with invasion and metastasis of bladder cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[28]  John N. Hutchinson,et al.  Caveolin-1 Gene Disruption Promotes Mammary Tumorigenesis and Dramatically Enhances Lung Metastasis in Vivo , 2004, Journal of Biological Chemistry.

[29]  D. Waisman,et al.  RNA Interference-mediated Silencing of the S100A10 Gene Attenuates Plasmin Generation and Invasiveness of Colo 222 Colorectal Cancer Cells* , 2004, Journal of Biological Chemistry.

[30]  J. Radich,et al.  Elevated expression of the AF1q gene, an MLL fusion partner, is an independent adverse prognostic factor in pediatric acute myeloid leukemia. , 2004, Blood.

[31]  L. Devy,et al.  Multifunctional role of matrix metalloproteinases in multiple myeloma: a study in the 5T2MM mouse model. , 2004, The American journal of pathology.

[32]  Jiong Wu,et al.  ERβ exerts multiple stimulative effects on human breast carcinoma cells , 2004, Oncogene.

[33]  B. Muehlenweg,et al.  Inhibition of the invasion capacity of carcinoma cells by WX‐UK1, a novel synthetic inhibitor of the urokinase‐type plasminogen activator system , 2004, International journal of cancer.

[34]  J. Peterse,et al.  Breast cancer metastasis: markers and models , 2005, Nature Reviews Cancer.

[35]  A. Weston,et al.  Transcriptional signatures of environmentally relevant exposures in normal human mammary epithelial cells: benzo[a]pyrene. , 2005, Cancer letters.

[36]  Pascal Reynier,et al.  Two-step differential expression analysis reveals a new set of genes involved in thyroid oncocytic tumors. , 2005, The Journal of clinical endocrinology and metabolism.

[37]  S. Eccles,et al.  Breast cancer metastasis: when, where, how? , 2005, The Lancet.

[38]  Luzhe Sun,et al.  Development and gene expression profiling of a metastatic variant , 2005, Cancer biology & therapy.

[39]  C. Perou,et al.  Molecular portraits and 70-gene prognosis signature are preserved throughout the metastatic process of breast cancer. , 2005, Cancer research.

[40]  J. Price.  Metastasis from human breast cancer cell lines , 2005, Breast Cancer Research and Treatment.

[41]  Z. Ou,et al.  Enhanced expression of Duffy antigen receptor for chemokines by breast cancer cells attenuates growth and metastasis potential , 2006, Oncogene.

[42]  Lei Wang,et al.  Identification of breast cancer metastasis‐associated proteins in an isogenic tumor metastasis model using two‐dimensional gel electrophoresis and liquid chromatography‐ion trap‐mass spectrometry , 2006, Proteomics.